HB 1150 Maryland House of Delegates · 2026 Regular Session

Health Occupations - Pharmacists - Minor Conditions and HIV Prevention and Treatment (Rapid Testing and Preventive Care Act)

HB 1150 expands pharmacists' scope of practice in Maryland to prescribe, administer, and dispense medications for specific minor conditions and HIV prevention/treatment under statewide protocols. It directly affects pharmacists (by allowing new clinical duties) and patients (by increasing access to care for conditions like cold sores, strep throat, flu, lice, urinary infections, and HIV testing). Key provisions include permitting pharmacists to prescribe for minor, self-limiting conditions without a new diagnosis and to perform/interpret HIV lab tests while prescribing PrEP/PEP medications. The bill repeals the previous nPEP standing order program and requires the Maryland Department of Health to establish these protocols.
Bill status passed 3 of 5 stages cleared
Introduction
Feb 2026
Committee Review
Mar 2026
House of Delegates Passage
Mar 2026
Senate Passage
Governor
Introduced Feb 11, 2026 Last action Mar 23, 2026
Maddy AI version diff · 1 comparison

What changed between versions

First - Health Occupations - Pharmacists - Minor Conditions and HIV Prevention and Treatment Third - Health Occupations - Pharmacists - Minor Conditions and HIV Prevention and Treatment (Rapid Testing and Preventive Care Act) · 4 edits
MODERATE
The bill was advanced to a third reading with amendments, expanding the scope of the law from a general framework to a specific 'Rapid Testing and Preventive Care Act.' The most significant substantive change is the addition of a new provision allowing pharmacists to perform and interpret HIV laboratory tests and prescribe pre- and post-exposure prophylaxis medications, which were previously restricted to specific sections. The bill also formally repeals the old 'nPEP Standing Order Program' and updates the list of minor conditions pharmacists can treat.
Scope change
The bill's scope expanded to explicitly include HIV rapid testing and the prescription of prophylaxis medications under the new title, moving beyond the previous limitations on pharmacist authority.
SCOPE

Added explicit authority for pharmacists to perform and interpret HIV laboratory tests and prescribe pre- and post-exposure prophylaxis medications.

DEFINITION

Renamed the legislation from a general act to the 'Rapid Testing and Preventive Care Act' to reflect the expanded scope of testing and preventive care.

REQUIREMENT

Removed the specific 'nPEP Standing Order Program' subtitle and repealed the associated standing order provisions, replacing them with new authority under the updated bill.

TECHNICAL

Added committee report and house action dates, and updated the list of sponsoring delegates to include additional names.

Floor votes · House of Delegates Mar 11, 2026

How they voted

10136
Passed · 5 other
Total votes 142
Mar 11, 2026
D Democratic103
99 Yea 4
96% Yea
R Republican39
2 Yea 36 Nay 1
92% Nay
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
8
Key actions
4
Committee
4
Mar 23, 2026
Committee
Referred Finance
upper
Mar 23, 2026
Lower · Passed
Third Reading Passed
lower
Mar 21, 2026
Lower · Passed
Favorable with Amendments {
lower
Mar 21, 2026
Lower · Passed
Favorable with Amendments Report by Health
lower
Mar 11, 2026
House Of Delegates · Passed
House of Delegates Vote: pass (101-36-5)
house of delegates
Feb 11, 2026
Committee
First Reading Health
lower
13 primary · 0 co-sponsors

Sponsors